The results of our study demonstrated the participation of DLGAP1-AS1 in regulating tumorigenesis and metastasis of HCC in vitro and in vivo, and suggested that DLGAP1-AS1 could be a potential target for the treatment of HCC. This evidence concerns the gene DLGAP1 and hepatocellular carcinoma.